Serous carcinogenesis in the fallopian tube: a descriptive classification.
about
Beyond CA125: the coming of age of ovarian cancer biomarkersOrigin and molecular pathogenesis of ovarian high-grade serous carcinomaThe oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.The disparate origins of ovarian cancers: pathogenesis and prevention strategies.Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceDysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in miceClaudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Ovarian cancer: a clinical challenge that needs some basic answers.The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tubeRole of CSF-1 in progression of epithelial ovarian cancerOpportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theoryReliable in vitro studies require appropriate ovarian cancer cell linesPrecursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tubeA genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube.Tubal origin of ovarian low-grade serous carcinoma.IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesisIMP3 signatures of fallopian tube: a risk for pelvic serous cancers.Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problemsThe immunomodulating roles of glycoproteins in epithelial ovarian cancer.Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic markerMolecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Carcinomas of Distal Fallopian Tube and Their Association with Tubal Intraepithelial Carcinoma: Do They Share a Common "Precursor" Lesion? Loss of Heterozygosity and Immunohistochemical Analysis Using PAX 2, WT-1, and P53 Markers.Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinomaCyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube.Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health StudyTechnical challenges and limitations of current mouse models of ovarian cancer.
P2860
Q24651567-F6B97963-3C66-4E1C-9409-A772E5894901Q26852698-6471A8CD-F036-41A6-8770-7A4E6DA0D70CQ27025315-11F1828F-145F-40FE-8750-D259D740CCDFQ27333756-8C8CC465-DD4E-49EC-9F67-1D535F6C17B4Q30240709-8DDAA29F-487B-47D4-B1F9-21357A684DD7Q30250107-F0992C66-999C-4732-B301-A5ECF09C7B16Q30414345-B97C3B94-0503-4666-B2DA-15F47C4426F9Q30491616-355432C7-F98E-4E17-9346-AAC10D28FEFEQ31141440-048302B6-A6A1-45FE-9BD4-7AC464F9784CQ33405559-ED9C8DBA-6932-4A1A-98F8-F88B829000CAQ33510967-B91C90C3-FCF6-4BED-A0E1-E6613FC52405Q33694369-AEBB062C-F6FA-4EE4-BB05-73723DB46155Q33735161-389F5662-56A9-4737-95C8-E05FF6209C7AQ33739695-F7D6274C-0512-4525-A879-1C5B6D4A5145Q33759421-A6CCE4D8-2F4C-42B0-8FC9-EF82EFEBF42AQ33815261-590E3427-3C34-4A7D-A1B9-1B47D0DB8754Q34039906-BB251293-C9A0-4576-B0AF-3B680A42894BQ34111959-841CE35E-FF6F-45B1-A934-79502CEB3EFCQ34201837-D7588032-E204-4231-B6A2-38FF35F9C879Q34383567-68C06D8B-324C-408B-8B3D-33DFE92BC208Q34468574-8828EAD1-00BD-435B-AA10-CBD7B35A70F4Q34504360-00EE02BA-7FEB-4B66-8612-11B2E5B1112AQ34669870-4E48848F-6018-4B06-A274-38E643920B17Q34836634-C711B22F-113E-48C1-92DD-49E6FE9D5056Q34977063-7B21C013-E97D-4724-90F0-270A474AC077Q34998994-B3A25871-DD9A-4A04-8266-6EAA75EE0822Q35077893-EC9FED8E-5144-4BEC-BF6B-88683370283CQ35089974-B29CA843-99C6-412C-B943-867043003DD5Q35140600-9E74246A-7F82-4702-91B2-D41EF59A651AQ35145201-10360532-8B5B-4224-8E99-2D1238FA5EFAQ35209384-325B9616-9BE8-4336-AAE5-6F333705526AQ35519808-983EB228-A33E-401B-96E1-7901A54833E8Q35897417-5CF520D8-8E40-4AFF-A525-705C186BE5D8Q36004053-AEF4D436-312E-4F4B-911B-A5BF6FEF71C7Q36039749-27A95E1B-DC33-43B9-A08B-6574CA42303DQ36101228-DEFF3185-1BB8-4C0B-9037-E44D0811E95EQ36182188-B3EB5658-01E5-468B-8908-98831EC1001BQ36309548-30722630-E32C-4A4C-98DC-265F92EF4356Q36421847-59E435B2-5463-48EF-A9B8-233DFC93DB94Q36510070-D0F81744-731B-4FF9-8CE2-452D54E1E1B5
P2860
Serous carcinogenesis in the fallopian tube: a descriptive classification.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@en
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@nl
type
label
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@en
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@nl
prefLabel
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@en
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@nl
P2093
P1476
Serous carcinogenesis in the fallopian tube: a descriptive classification.
@en
P2093
Alexander Miron
Ann Folkins
Christopher P Crum
David Kindelberger
Elke Jarboe
Marisa R Nucci
Yonghee Lee
P356
10.1097/PGP.0B013E31814B191F
P577
2008-01-01T00:00:00Z